Regulatory 2022-03-31 | Number of shares and votes in Ascelia Pharma AB PDF Report Presentation Webcast
2022-03-31 | Ascelia Pharma AB: HC Andersen Capital: Release of new Ascelia Pharma investment case PDF Report Presentation Webcast
2022-03-22 | New independent market research says 84% US healthcare professionals likely to use Orviglance imaging agent in target population PDF PDF Report Presentation Webcast
2022-03-11 | Ascelia Pharma successfully completes Orviglance Hepatic Impairment Study PDF Report Presentation Webcast
Regulatory 2022-03-07 | Ascelia Pharma suspends clinical activities in Russia PDF Report Presentation Webcast
2022-03-02 | Issue and repurchase of series C shares for share saving program PDF Report Presentation Webcast
2022-02-15 | Results from Orviglance comparison study to gadolinium accepted for oral presentation at the ESGAR conference PDF Report Presentation Webcast
Regulatory 2022-02-10 | Quarterly Report Q4 2021: Strong data for Orviglance vs. a gadolinium contrast agent PDF Report Presentation Webcast